HeartSciences Inc. has secured its first commercial SaaS revenue agreement with St. Vincent Health to deploy its MyoVista Insights platform, marking a key milestone from early adopter installations to revenue-generating deployments. MyoVista Insights is a cloud-based ECG management system that integrates AI to improve clinical workflows and is device-agnostic, designed to scale across healthcare facilities. The company expects more commercial agreements in the coming quarters as it gains market interest following its full launch at the American College of Cardiology Annual Scientific Session. This deal highlights HeartSciences' transition to mainstream commercial operations and its potential growth in healthcare technology adoption.
Warner Bros. Discovery's stock fell 4% following a court decision to pause the $110 billion merger deal between Paramount and Skydance. The judge's intervention raises uncertainty about the future of this major entertainment industry consolidation. I...
The CLARITY Act, a key bill aimed at providing clear federal guidelines for digital assets, is facing a vote shortfall in the Senate with only about 51 confirmed or likely yes votes, below the 60 needed. Republican support remains strong, but Democra...
Bitcoin faces a potential drop to $45,000 by early October 2026, linked to patterns seen in past crypto exchange failures like Mt. Gox and FTX. The planned shutdown of BitMEX signals a possible market capitulation phase, with Bitcoin trading near key...
XRP's exchange activity on Binance has sharply declined, dropping from about 650,000 to 350,000 deposits and withdrawals, signaling reduced selling pressure and increased holding. Meanwhile, the NVT Ratio surged, indicating XRP's market value is grow...
Prediction markets on Kalshi assign a 59% probability that XRP will trade below $1 before the end of 2026, reflecting weakened confidence in a sustained recovery despite a recent modest rebound. XRP has struggled to maintain momentum, repeatedly movi...
